Tag: Amgen
FDA Pauses Study on Amgen’s Obesity Treatment
The Food and Drug Administration (FDA) recently put a hold on Amgen's study of their early-stage obesity treatment, known as AMG 513, marking a potential setback for the company in the competitive weight loss...
